June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
IL-6 drives Treg dysfunction in desiccating stress-induced dry eye disease
Author Affiliations & Notes
  • Gustavo Ortiz
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Francesca Kahale
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Tomas Blanco
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Amirreza Naderi
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Yihe Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Reza Dana
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Gustavo Ortiz None; Francesca Kahale None; Tomas Blanco None; Amirreza Naderi None; Yihe Chen None; Reza Dana None
  • Footnotes
    Support  R01EY020889
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 895 – A0259. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gustavo Ortiz, Francesca Kahale, Tomas Blanco, Amirreza Naderi, Yihe Chen, Reza Dana; IL-6 drives Treg dysfunction in desiccating stress-induced dry eye disease. Invest. Ophthalmol. Vis. Sci. 2022;63(7):895 – A0259.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have demonstrated that T regulatory cells (Tregs) become dysfunctional during dry eye disease (DED) being less able to control pathogenic Th17 cells. Th17-associated cytokines (IL-6, IL-17, IL-23) are implicated in altering Treg function; however, the precise functions of these cytokines on Treg in DED have remained unclear.

Methods : Using a controlled environmental chamber, female C57BL/6 mice were exposed to desiccating stress (relative humidity 10% vs. ~40% normal environment) to induce DED. Western blot of IL-6R, IL-17RA, IL-23R was performed on isolated Tregs (using magnetic activated sorting) from naïve and DED animals. Mean Fluorescent Intensity (MFI) of FoxP3, CD25, CTLA-4 and GITR of naïve and DED Tregs was measured using flow cytometry. Isolated naïve Tregs were in vitro stimulated with 20 ng/ml of IL-6, IL-17A and 30 ng/ml of IL-23 separately for 24 and 72hs. MFIs of IL-6R, IL-17RA, IL-23R, FoxP3, CD25, CTLA-4 and GITR were analysed. The cytokine-stimulated Tregs were then co-cultured with in vitro differentiated Th17 cells for 72hs. Treg suppression assay was calculated as % of inhibition of Th17 cells by flow cytometry. IL-10 and TGFβ1 supernatant levels (in Treg-Th17 co-culture) were quantified by ELISA.

Results : DED Tregs expressed higher levels of cytokine receptors IL-6R (p=0.004), IL-17RA (p<0.001), IL-23R (p=0.002) and lower levels of FoxP3 (p<0.001), CD25 (p=0.013) and CTLA-4 (p=0.022) as compared to naïve Tregs. Culturing Tregs with each of the three Th17-associated cytokines all led to a significant decrease in FoxP3 (p<0.01), CD25 (p<0.05) and CTLA-4 (p<0.05) expression. Conversely, IL-6 and IL-17 enhanced expression of IL-6R (p<0.001 for both), IL-17RA (p<0.05 for both), IL-23R (p<0.001 for IL-6; p<0.05 for IL-17). The suppressive function on Th17 by cytokine-stimulated Tregs was reduced with IL-6 being the most potent at rendering Tregs dysfunctional (31.2 ± 4.2% vs. 63.4 ± 2.3% naïve; p=0.043). IL-6-stimulated Tregs produced significantly less IL-10 (79.6 ± 6.5 pg/ml) as compared to unstimulated Tregs (198.6 ± 19.4; p<0.001).

Conclusions : These results suggest that IL-6 is the most potent cytokine that drives Treg dysfunction in DED, and thus can be a promising therapeutic target for restoring Treg function and reducing disease severity.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×